NPI Verification Comes Before Anything Else
Precision Biologics checks every applicant's National Provider Identifier against NPPES before activating an account, which for a pain management group usually means the account is tied to a single ordering physician even if the group includes multiple providers across pain medicine and physical medicine and rehabilitation.
Practices that operate across both specialties under one tax ID should still expect the account itself to be verified at the individual physician level.
Birmingham
NPPES registry listings, primary taxonomy, retrieved 2026-10-27
134- Pain Medicine
- 48
- Physical Medicine & Rehabilitation
- 86
Documentation Pain Management and PM&R Groups Request
Verified accounts can request the certificate of analysis, donor eligibility summary and lot release record for a specific lot, and for exosome products, the supplier's reported characterization data, including nanoparticle tracking analysis, ELISA and SP-IRIS results and the growth-factor and cytokine panel reported for Bio Xsomes.
Full ingredient disclosures for lyophilized formats such as Bio EX and Bio AER are also available to verified accounts rather than published.
Southeast Delivery Logistics
Cryopreserved products arrive overnight on dry ice in validated shipping containers and need to move into -80 degree Celsius storage promptly; Birmingham-area practices should build summer heat into their receiving plan, since high ambient temperatures reduce how long a dry-ice shipment can safely wait before it is brought inside.
Lyophilized exosome and Wharton's jelly formats are shelf-stable under normal storage, which removes that constraint for practices that prefer not to maintain ultra-low freezer capacity.
Regulatory Verification Stays With the Practice
Precision Biologics directs every Birmingham practice to confirm its own licensure with the Medical Licensure Commission of Alabama and to work with practice counsel on how a given intended use is evaluated under 21 CFR 1271.10, and, for exosome products, under section 351 biologic drug regulation.
Support from Precision Biologics during account setup covers NPI verification, documentation requests and a physician-level call about paperwork; it does not extend to advice on clinical use, dosing or procedure.
FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.
These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.
Frequently asked questions
Is Bio Xsomes approved by FDA for use in a Birmingham pain management practice?+
No. FDA has stated there are no FDA-approved exosome products. Purchase and clinical use decisions, including whether a product fits a practice's regulatory posture, remain with the physician and practice counsel.
Can a combined pain medicine and physical medicine and rehabilitation practice use one shared account?+
Accounts are verified by individual NPI rather than by practice, so a combined group should expect one ordering physician's NPI to anchor the account even if multiple specialties operate under the same practice.
What is the fastest way for a Birmingham practice to start the account process?+
Submit an NPI for verification against NPPES and request the standard documentation package; Precision Biologics can arrange a physician-level call to walk through that documentation once the account is verified.